| Section | Provisional content |
|---|---|
| SYCE1-related gametogenic failure: provisional research report (uncited) | **Retrieval block:** no retrievable papers and no citable context IDs were available in this session, so no tool-grounded citations were possible. All publication-specific statements below are provisional and require manual verification against the seed PubMed records: PMID:25062452 — https://pubmed.ncbi.nlm.nih.gov/25062452/ ; PMID:32402064 — https://pubmed.ncbi.nlm.nih.gov/32402064/ ; PMID:34718620 — https://pubmed.ncbi.nlm.nih.gov/34718620/ ; PMID:35718780 — https://pubmed.ncbi.nlm.nih.gov/35718780/ |
| Executive judgment | **Partially supported (provisional).** The seed evidence is consistent with biallelic or otherwise damaging **SYCE1** variants causing meiotic failure through synaptonemal-complex dysfunction, but confidence is limited because the underlying papers could not be retrieved or independently verified in this run. |
| Key concepts / definitions | **SYCE1** is a synaptonemal-complex central element protein involved in meiotic prophase I. The seed hypothesis proposes that SYCE1 deficiency impairs central element assembly and interactions with **SYCP1** and **C14ORF39/SIX6OS1**, leading to homologous chromosome synapsis failure, meiotic arrest, and infertility. |
| Recent developments | **Unavailable in this run.** 2023-2024 literature could not be retrieved with the available tools, so newer cohorts, structural studies, or mechanistic refinements could not be prioritized. |
| Applications / real-world implementations | Provisional practice implications include adding **SYCE1** to infertility, POI, and NOA genetic panels with **CNV detection**, and considering gonadal phenotype-specific workup in reproductive medicine settings. Real-world implementation details specific to SYCE1 could not be verified from retrievable sources here. |
| Expert opinions | Seed-author conclusions, treated here as **unverified**, include: familial human evidence linking homozygous nonsense SYCE1 variation to POI/primary amenorrhea; model evidence supporting infertility through SYCE1 loss and synapsis defects; functional evidence that some variants disrupt interaction with **SYCP1** or **C14ORF39/SIX6OS1**; and human male histology suggesting pachytene-stage arrest in SYCE1-associated NOA. |
| Statistics / data | **Unavailable.** No verified cohort sizes, prevalence estimates, endocrine values, biopsy frequencies, or quantitative assay results could be extracted in this run because no source texts were retrievable. |
| Evidence matrix pointer | Seed evidence spans four main classes: human familial genetics (PMID:25062452), mouse/model loss-of-function evidence (PMID:32402064), in vitro interaction / SC assembly evidence (PMID:34718620), and human NOA histology/CNV evidence (PMID:35718780). |
| Clinical spectrum | **46,XX:** primary ovarian insufficiency / primary amenorrhea. **46,XY:** non-obstructive azoospermia with reported pachytene-stage spermatogenic arrest on H&E / immunofluorescence. Detailed FSH, AMH, LH, testosterone, ovarian imaging, follicle depletion, and full biopsy-marker data were not retrievable here. |
| Variant / inheritance | Provisional inheritance model: **autosomal recessive / biallelic**. Seed evidence mentions a **homozygous nonsense variant c.613C>T**, additional damaging variants affecting protein interactions, and **SYCE1 CNVs**; exact zygosity, phasing, family counts, and ACMG-style classifications require manual confirmation. |
| Mechanistic causal chain | Provisional chain: **biallelic SYCE1 loss/damaging variant -> reduced or absent SYCE1 -> disrupted interaction with SYCP1 and/or C14ORF39/SIX6OS1 -> synaptonemal-complex central element assembly failure -> homologous chromosome synapsis failure -> pachytene arrest/checkpoint activation -> germ-cell depletion -> 46,XX POI/primary amenorrhea or 46,XY NOA/spermatogenic arrest**. Intermediate links are partly model/in vitro based and remain unverified here. |
| Diagnostics / management | Provisional implications: include **SYCE1** on infertility/POI/NOA testing panels with CNV calling; in **46,XY**, consider semen analysis, endocrine evaluation, and biopsy when clinically indicated; in **46,XX**, assess ovarian reserve and POI biochemistry. Management is expected to follow standard care pathways such as hormone replacement for POI, fertility counseling, donor-oocyte discussion for POI, and cautious consideration of micro-TESE/ICSI in NOA. |
| Ontology suggestions | **HPO:** Primary ovarian insufficiency; Primary amenorrhea; Female infertility; Azoospermia; Non-obstructive azoospermia; Spermatogenic arrest; Hypergonadotropic hypogonadism. **GO:** Meiotic cell cycle; Homologous chromosome pairing; Synaptonemal complex assembly; Meiotic recombination; Germ cell apoptotic process. **CL:** Primary oocyte; Spermatocyte; Pachytene spermatocyte; Germ cell. **Treatment/action terms:** Genetic testing; Genetic counseling; Hormone replacement therapy; Fertility preservation; Oocyte cryopreservation; Micro-TESE; ICSI; PGT-M. |
| Knowledge gaps | Major gaps are caused by the retrieval block: no verified full texts, no figure/table access, no direct extraction of endocrine or histology data, uncertain CNV zygosity/phasing, and limited ability to separate direct human evidence from mouse or in vitro inference. Evidence for checkpoint activation or apoptosis in human tissue remains especially uncertain. |
| Curation leads | Provisional leads requiring curator verification: (1) annotate the disease mechanism as a **meiotic synaptonemal-complex central element assembly defect**; (2) capture the dual-sex phenotype of **46,XX POI/primary amenorrhea** and **46,XY NOA/pachytene arrest**; (3) note support for **loss-of-function and CNV** mechanisms; (4) add the partner-interaction mechanism involving **SYCP1** and **C14ORF39/SIX6OS1**; (5) manually review the seed PMIDs for exact variant nomenclature, segregation, assay systems, and any newer follow-up literature. |


*Table: This table provides a seed-anchored, provisional research report for SYCE1-related gametogenic failure. It summarizes the requested mechanism, phenotype, variant, and curation elements while explicitly documenting that literature retrieval failed and no tool-grounded citations were possible.*